-
- Results Of A Phase 2 Study Of Neflamapimod 80mg Twice-daily In Dementia With Lewy Bodies [Board No. Tuesday-0020]
-
Board no. Tuesday-0020
Frédéric Blanc1, Anne Botzung, PhD2, Claire Hourregue3, Agathe Vrillon, MD, PhD4, Alexandra Fayel5, Candice Muller1, Catherine Demuynck1, Jeanne Merignac1, Timothée Albasser1, Alix Ravier1, Fabienne Saab1, Fanny Huselstein1, Ajit Chavan6, Jennifer Conway6, Nathalie Adda6, John Alam7, Claire Paquet3.
1Service of Gerontology-Neuro-Psy-Research and Memory Clinic (CM2R), University Hospital of Strasbourg, Strasbourg, France, 2Memory clinic, Strasbourg University Hospital, Strasbourg, France, 34Cognitive Neurology Center, AP-HP, Paris, France, 5AP-HP, Paris, France, 6Cervomed, Boston, MA, USA, 7CervoMed, Inc., Boston, MA, USA.Types
Enter Note
Go to previous page in this tab
Session